The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Development and Validation of the Cystic Fibrosis Questionnaire in the United States
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Convergent and discriminant validation by the multitrait-multimethod matrix.
Campbell, D. T., & Fiske, D. W. (1959) · Psychological Bulletin · doi:10.1037/h0046016 · Cited by 17,116
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
MCHORNEY, C. A., JOHNE, W., & ANASTASIAE, R. (1993) · Medical Care · doi:10.1097/00005650-199303000-00006 · Cited by 6,681
The St George's Respiratory Questionnaire
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,683
Quality of life and pharmacoeconomics in clinical trials
Spilker, B. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,862
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Self-citationMeasuring Quality of Life in Asthma
Juniper, E. F., Guyatt, G. H., Ferrie, P. J., & Griffith, L. E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.832 · Cited by 887
Cited by
Spruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation
Accurso, F. J., Rowe, S. M., Clancy, J. P., Boyle, M. P., Dunitz, J. M., Durie, P. R., Sagel, S. D., Hornick, D. B., Konstan, M. W., Donaldson, S. H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909825 · Cited by 807
Clancy, J. P., Rowe, S. M., Accurso, F. J., Aitken, M. L., Amin, R. S., Ashlock, M. A., Ballmann, M., Boyle, M. P., Bronsveld, I., Campbell, P. W., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200393 · Cited by 515
High treatment burden in adults with cystic fibrosis: challenges to disease self-management
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.007 · Cited by 498
Rowe, S. M., Heltshe, S. L., Gonska, T., Donaldson, S. H., Borowitz, D., Gelfond, D., Sagel, S. D., Khan, U., Mayer-Hamblett, N., Van Dalfsen, J. M., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201404-0703oc · Cited by 492
Boyle, M. P., Bell, S. C., Konstan, M. W., McColley, S. A., Rowe, S. M., Rietschel, E., Huang, X., Waltz, D., Patel, N. R., & Rodman, D. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70132-8 · Cited by 452
Quittner, A. L., Modi, A. C., Wainwright, C., Otto, K., Kirihara, J., & Montgomery, A. B. (2009) · Chest · doi:10.1378/chest.08-1190 · Cited by 400
Self-citationEfficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
De Boeck, K., Munck, A., Walker, S., Faro, A., Hiatt, P., Gilmartin, G., & Higgins, M. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.09.005 · Cited by 394
Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis
McCoy, K. S., Quittner, A. L., Oermann, C. M., Gibson, R. L., Retsch-Bogart, G. Z., & Montgomery, A. B. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1804oc · Cited by 356
Self-citationIvacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation
Flume, P. A., Liou, T. G., Borowitz, D. S., Li, H., Yen, K., Ordoñez, C. L., & Geller, D. E. (2012) · Chest · doi:10.1378/chest.11-2672 · Cited by 338
Ong, T., & Ramsey, B. W. (2023) · JAMA · doi:10.1001/jama.2023.8120 · Cited by 315
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
Retsch-Bogart, G. Z., Quittner, A. L., Gibson, R. L., Oermann, C. M., McCoy, K. S., Montgomery, A. B., & Cooper, P. J. (2009) · Chest · doi:10.1378/chest.08-1421 · Cited by 281
Self-citationDavis, E., Waters, E., Mackinnon, A., Reddihough, D., Graham, H. K., Mehmet-Radji, O., & Boyd, R. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206000673 · Cited by 267
McKone, E. F., Borowitz, D., Drevinek, P., Griese, M., Konstan, M. W., Wainwright, C., Ratjen, F., Sermet-Gaudelus, I., Plant, B., Munck, A., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70218-8 · Cited by 211
Riekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S. (2007) · Chest · doi:10.1378/chest.06-2474 · Cited by 197
Lechtzin, N., Mayer-Hamblett, N., West, N. E., Allgood, S., Wilhelm, E., Khan, U., Aitken, M. L., Ramsey, B. W., Boyle, M. P., Mogayzel, P. J., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201610-2172oc · Cited by 127
“Secondary Outcome Measures with Defined Units Outcome Measure Unit CFQ-R (21) 52-wk change CFRSD (15) 52-wk change FEV1, % predicted 52-wk change FVC, L 52-wk change FEF25–75%, L/s 52-wk change Time to first acute protocol-defined PE Time in days Time from first acute PE to subsequent PE Time in days Number of hospita…”
BackgroundQuality of life in patients with Cystic Fibrosis: association with anxiety and depression
Havermans, T., Colpaert, K., & Dupont, L. J. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.05.010 · Cited by 124
Sawicki, G. S., Rasouliyan, L., McMullen, A. H., Wagener, J. S., McColley, S. A., Pasta, D. J., & Quittner, A. L. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21325 · Cited by 106
“The CFQ-R assesses functioning and HRQOL during the 2-week period before its administration.(3,15) Each CFQ-R scale yields standardized scale scores ranging from 0 to 100, with higher scores indicating better HRQOL.”
MethodSelf-citationHegarty, M., MacDonald, J., Watter, P., & Wilson, C. (2009) · Child: Care, Health and Development · doi:10.1111/j.1365-2214.2008.00900.x · Cited by 71
Acceptance and well-being in adolescents and young adults with cystic fibrosis: A prospective study
Casier, A., Goubert, L., Theunis, M., Huse, D., De Baets, F., Matthys, D., & Crombez, G. (2011) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsq111 · Cited by 60
Body image and cystic fibrosis: A critical review
Tierney, S. (2012) · Body Image · doi:10.1016/j.bodyim.2011.09.001 · Cited by 47
Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R
Schmidt, A., Wenninger, K., Niemann, N., Wahn, U., & Staab, D. (2009) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-7-97 · Cited by 37
Health-related quality of life in cystic fibrosis
Royce, F. H., & Carl, J. C. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834a7829 · Cited by 27
Solé, A., Pérez, I., Vázquez, I., Pastor, A., Escrivá, J., Sales, G., Hervás, D., Glanville, A. R., & Quittner, A. L. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2016.01.1233 · Cited by 26
Self-citationThe feasibility of home monitoring of young people with cystic fibrosis: results from CLIMB-CF
Edmondson, C., Westrupp, N., Seddon, P., Olden, C., Wallis, C., Dawson, C., Brodlie, M., Baxter, F., McCormick, J., MacFarlane, S., et al. (2022) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2021.09.018 · Cited by 26
Positive mental health and wellbeing in adults with cystic fibrosis: a cross sectional study
Cronly, J., Duff, A., Riekert, K., Horgan, A., Lehane, E., Perry, I., Fitzgerald, A., Howe, B., Chroinin, M. N., & Savage, E. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.11.016 · Cited by 24
Hoo, Z. H., Boote, J., Wildman, M. J., Campbell, M. J., & Gardner, B. (2017) · Health Psychology and Behavioral Medicine · doi:10.1080/21642850.2017.1338958 · Cited by 21
The Use of Home Spirometry in Pediatric Cystic Fibrosis Patients: Results of a Feasibility Study
Shakkottai, A., & Nasr, S. Z. (2017) · Global Pediatric Health · doi:10.1177/2333794x17690315 · Cited by 16
Airway clearance and exercise for people with cystic fibrosis: balancing longevity with life
Rowbotham, N. J., & Daniels, T. E. (2022) · Pediatric Pulmonology · doi:10.1002/ppul.25734 · Cited by 16
O'Hayer, C. V., Smith, P. J., Drescher, C. F., Bruschwein, H., Nurse, C. N., Kushner, H. M., Ingle, K., Stephen, M. J., & Hoag, J. B. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.11.011 · Cited by 12
Yoga as a therapy for adolescents and young adults with cystic fibrosis: a pilot study
Ruddy, J., Emerson, J., Mcnamara, S., Genatossio, A., Breuner, C., Weber, T., & Rosenfeld, M. (2015) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2015.061 · Cited by 9
Metadata
- Authors
- Quittner, A. L., Buu, A., Messer, M. A., Modi, A. C., & Watrous, M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2005-10
- Volume
- 128
- Issue
- 4
- Pages
- 2347-2354
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2131236190
- Cited by
- 507
- References
- 40
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.